Why the study?
Do low-molecular-weight heparins improve efficacy and safety compared to other anticoagulants for venous thromboembolism prophylaxis in patients undergoing major orthopedic surgery?
Do low-molecular-weight heparins improve efficacy and safety compared to other anticoagulants for venous thromboembolism prophylaxis in patients undergoing major orthopedic surgery?
LMWHs offer a favorable balance of efficacy and safety compared to UFH, but factor Xa inhibitors and DTIs may provide better efficacy than LMWHs with acceptable safety profiles in major orthopedic surgery.
LMWHs balance efficacy and safety better than UFH in orthopedic VTE prophylaxis; reinforces their preference while extending evidence for factor Xa inhibitors' superior efficacy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Sobieraj et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: